The mission of the BIH is medical translation: The BIH aims to translate findings from biomedical research into new approaches for personalized prediction, prevention and therapy and, conversely, to develop new research approaches from clinical observations.
We are interested in how T cells protect us from viral infections and chronic diseases caused by pathogens, tumors or autoimmunity. To this end, we are developing technologies that can detect, characterize and genetically reprogram T cell specificity, as well as strategies to optimize the quality of T cells for therapeutic purposes. Our goal is to develop diagnostic tools to predict the immune response, as well as to provide new treatment options by developing appropriate T cell products.
Fraunhofer-Gesellschaft